Colorectal

BELLOXA

Indication :  Oxaliplatin in combination with 5-Fluorouracil (5-FU) and folinic acid (FA) is indicated for: adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumor treatment of metastatic colorectal cancer   Compositions : Each mL contain Oxaliplatin 5 mg   Storage Condition :  Store below 30°C, in a hermetic container.  […]

BELLOXA Read More »

KEMOPIRIN

Indication :  Epirubicin HCl administered as single agent has shown to produce regression in a broad spectrum of tumors including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Preliminary findings indicate that the drug has produce some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with other

KEMOPIRIN Read More »

OXALIPLATIN

Indication :  Oxaliplatin in combination with 5-Fluorouracil (5-FU) and folinic acid (FA) is indicated for: adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumor treatment of metastatic colorectal cancer   Compositions : Eeach mL contain Oxaliplatin 5 mg   Storage Condition :  Store below 30°C, in a hermetic container. 

OXALIPLATIN Read More »

EPIRUBICIN

Indication :  Epirubicin HCl administered as a single agent has shown to produce regression in a broad spectrum of tumours including mammary carcinoma, malignant lymphomas, soft tissue sarcomas and gastric cancer. Prelimenary findings indicate that the drug has produced some anti tumor activity in malignant melanoma and in advanced colorectal carcinoma. Given in combination with

EPIRUBICIN Read More »

Need More Information?

Contact CKD OTTO Pharma now for more information about our products and services.

Scroll to Top